Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
                                 
 

Journal of Leukemia

 
Review in 3 weeks         Publishing in 72 hours          Open Access  
 
ISSN: 2329-6917
 
 
 
HOME » JOURNALS » LEUKEMIA french  |  English
 
 
 
 
 

Upcoming Event

 

Upcoming Special Issues

Special issue entitled: "Myeloma" has been edited by
 
 

Guido J.K. Tricot
Professor of Medicine
University of Iowa Hospitals and Clinics
Iowa City, Iowa, USA
Tel: 319-356-3425
 

 
Special issue entitled: "Bone Marrow Transplantation" has been edited by
 
 

Susumu Ikehara
Professor
Department of Stem Cell Disorders
Kansai Medical University
Japan
Tel: 81-72-804-2450
 

 
Read More»
 

About the Journal

Leukemia is malignancy of any cellular element in the blood or bone marrow. Journal of Leukemia (JL) is a peer reviewed medical journal that includes a wide range of fields in leukemias, lymphomas, multiple myeloma, epidemiologic studies and other hematologic malignancies and creates a platform for the authors to make their contribution towards the journal and the editorial office promises peer process for the submitted manuscripts to ensure quality.

 

JL is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide  online access without any restrictions or any other subscriptions to researchers worldwide

This scholarly open access journal is using Editorial Tracking System to maintain quality in the review process. Editorial Tracking is an online manuscript submission, review and the progress of the article. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript. Authors may submit manuscripts and track its progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

 

Journal of Leukemia is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.

flyer image

ISSN: 2329-6917
NLM ID: 101620394

 

OMICS Group International is a leading Open Access publisher that publishes more than 500+ peer-reviewed Open Access Journals and organizes over 300+ International Conferences globally with the support of nearly 1000 International Societies. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.

 
The journal is using Editorial manager System for quality in review process. Editorial manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process
 

Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jlu@omicsonline.org

Journal of Leukemia is organizing 5th World Conference on Cancer Therapy during september 28-30, 2015 Atlanta, USA with the theme of Exploring the Possibilities towards cancer treatment.

 

Recently published articles

Staging and Prognostic Factors in Chronic Lymphocytic Leukemia: Current Status

Tadeusz Robak

 
Dissecting the In Vivo Leukemogenic Potency of Bclxl

Kumar Saurabh, Michael T Scherzer, Amy Song, Kenneth W Yip, John C Reed, Chi Li, Levi J Beverly

 
Cancer Stem Cells in Chronic Myelogenous Leukemia

Gabriella Marfe and Carla Di Stefano

 
Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment

Ashley E Rosko, Karen S McColl, Fei Zhong, Christopher B Ryder, Ming-Jin Chang, Abdus Sattar, Paolo F Caimi, Brian T Hill, Sayer Al-Harbi, Alexandru Almasan and Clark W Distelhorst

 
Myeloid Neoplasms Associated with t(3;12)(q26.2;P13) Are Clinically Aggressive and Frequently Harbor FLT3 Mutations: A Report of 8 Cases and Review of Literature

Xiaohong I Wang, Xinyan Lu, Cameron Yin C, Lian Zhao, Carlos E Bueso-Ramos, Jeffrey Medeiros L, Shaoying Li, Heesun J Rogers, Eric D Hsi and Pei Lin

 
Leukemia and the Peripheral Nervous System: A review

Wolfgang Grisold, Anna Grisold, Johannes Hainfellner , Stefan Meng and Christine Marosi

 
High Induction Response Rate, but Poor Long-Term Disease Free Survival in Elderly Patients Treated Aggressively for Acute Lymphoblastic Leukemia

Adisak Tantiworawit, Walaa A Rajkhan, Michael J Barnett, John D Shepherd, Alina S Gerrie, Raewyn Broady, Donna L Forrest , Donna E Hogge, Stephen H Nantel, Sujaatha Narayanan, Thomas J Nevill, Maryse M Power, Heather J Sutherland, Cynthia L Toze, Kevin W Song and Yasser R Abou Mourad

 
A Challenging Case of IgD Kappa Multiple Myeloma Associated With Primary Amyloidosis: Importance of Serum Free Light Chains in Monitoring Treatment Response and Disease Relapse

José Luis García de Veas Silva, Carmen Bermudo Guitarte, Paloma Menéndez Valladares, Rafael Duro Millán and Johanna Carolina Rojas Noboa

 
Is It Feasible to Apply Preference-Based Quality-of-Life Measures on Patients with Chronic Myeloid Leukemia?

Teng-Chou Chen and Li-Chia Chen

 
CD30+ Cells in Lung of Indolent Type Adult T-Cell Leukemia/Lymphoma and Elevated Serum Levels of Soluble CD30 Associated with Acute Crisis and Relapse of Disease

Shigeki Takemoto, Yoshitaka Morimatsu, Ratiorn Pornkuna, Toshihiko Murayama and Fumio Kawano

 
The Challenge of t(6;9) and FLT3-Positive Acute Myelogenous Leukemia in a Young Adult

Yeohan Song, Dale Bixby, Diane Roulston, John Magenau and Sung Won Choi

 
 
 
 
 
Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country
   USA    Spain
   Australia   Canada
   UAE   China
   Italy   France
   Germany   India
   UK   Malaysia
   Japan   Singapore
   Brazil   South Africa
  South Korea
 
Conferences By City
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
 
Conferences By Subject
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
 
 
© 2008-2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version